Medacta Delivers Strong Organic Growth In First Half

Medacta reported 1H23 orthopedic sales of €255.2 million ($275.6 million USD), +20.8% compared to the first half of 2022.

The company kept its organic growth momentum after growing more than 20% in both 2021 and 2022. In addition to continued strong performances in the EMEA region, Medacta saw recoveries in the APAC and U.S. markets as...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us